Clinical and Laboratory Predictors of Respiratory Morbidities in CP Children

September 18, 2021 updated by: Remonda Ramsis Hennis

Clinical and Laboratory Predictors of Respiratory Morbidities in Children With Cerebral Palsy at Assiut University Children Hospital

Relationship between respiratory morbidities and cerebral palsy in children

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Identification of symptoms,signs,severity and outcomes of respiratory morbidities in children with Cp

Study Type

Observational

Enrollment (Anticipated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Identification of different respiratory problems in children with cerebral palsy

Description

Inclusion Criteria:

  • children with CP from 1 month to 18 years

Exclusion Criteria:

  • neonates with Cp CP patients more than 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest auscultation
Time Frame: Baseline
Identify any respiratory abnormalities in CP patients
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest X-ray
Time Frame: Baseline
Identify any chest infection in CP patients
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Remonda Ramsis Hennis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2021

Primary Completion (Anticipated)

October 1, 2022

Study Completion (Anticipated)

January 1, 2023

Study Registration Dates

First Submitted

March 25, 2021

First Submitted That Met QC Criteria

September 18, 2021

First Posted (Actual)

September 22, 2021

Study Record Updates

Last Update Posted (Actual)

September 22, 2021

Last Update Submitted That Met QC Criteria

September 18, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Respiratory morbidities in CP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recurrent Respiratory Tract Infections

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe